Cancer: Inhibiting ROCK in neuroblastoma
Nature Reviews Drug Discovery 16, 602 (2017).
doi:10.1038/nrd.2017.160
Author: Crunkhorn Sarah
Neuroblastoma is a childhood tumour originating from the neural crest, for which treatment options are limited. Dyberg et al. report a high frequency of mutations in genes associated with RHO–RAC signalling in human neuroblastoma samples. Increased expression of the downstream RHO-activating kinase ROCK2 was
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: CrunkhornSarah Tags: Research Highlight Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Childhood Cancer | Drugs & Pharmacology | Genetics | Neuroblastoma | Neurology